John Joseph, MD
Pain Medicine · Menasha, WINPI 1801828074
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,603 of the $2,972 with a category attached, or 87.6%. It is spread thinly across 21 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,090, 3.6 times the $305 reported in 2019. That places this record below the midpoint for pain medicine clinicians in WI, where the typical reported total is $2,566.
Across 95 payments — averaging $31.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$633
- Nalu Medical, Inc.$452
- Saluda Medical Americas, Inc.$393
- Teva Pharmaceuticals USA, Inc.$215
- Collegium Pharmaceutical, Inc.$181
- Stimwave Technologies Incorporated$180
- plus $917 from 15 others
What the payments were for
- Travel & lodging$2248%
- Food & beverage$2,60388%
- Education$1455%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $633 |
| Nalu Medical, Inc. | 4 | $452 |
| Saluda Medical Americas, Inc. | 2 | $393 |
| Teva Pharmaceuticals USA, Inc. | 4 | $215 |
| Collegium Pharmaceutical, Inc. | 14 | $181 |
| Stimwave Technologies Incorporated | 1 | $180 |
| Tersera Therapeutics LLC | 3 | $146 |
| Si-bone, Inc. | 1 | $139 |
| Boston Scientific | 2 | $131 |
| Boehringer Ingelheim | 1 | $125 |
| IBSA Pharma Inc. | 7 | $98 |
| Lilly USA, LLC | 3 | $47 |
| Averitas Pharma Inc. | 2 | $45 |
| Johnson & Johnson | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Pfizer | 2 | $32 |
| Tonix Medicines, Inc. | 1 | $24 |
| Foundation Fusion Solutions, LLC | 1 | $17 |
| Braeburn Inc. | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Electronic Waveform Lab, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$393
- Nalu Neurostimulation System$224
- Mavyret$125
- JARDIANCE$125
- PRIALT$110
- AJOVY$109
- GENERAL PAIN MANAGEMENT$104
How this compares
$2,972 in reported general payments places this provider in the 50th percentile of 82 pain medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 86 | $52,714 |
| Buprenorphine | 133 | $38,297 |
| NucyntaTapentadol Hcl | 23 | $31,699 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 710 | $19,496 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 111 | $11,134 |
| Morphine Sulfate ErMorphine Sulfate | 259 | $6,196 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 176 | $5,795 |
| OxycontinOxycodone Hcl | 12 | $5,017 |
| Buprenorphine Hcl | 196 | $4,807 |
| Colchicine | 73 | $3,825 |
| Gabapentin | 323 | $3,813 |
| Lidocaine | 27 | $3,402 |
| Pregabalin | 169 | $3,402 |
| Duloxetine Hcl | 119 | $1,951 |
| Baclofen | 104 | $1,635 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta | $181 | $84,412109 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Buprenorphine Hcl, Morphine Sulfate | $35 | $55,634495 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 82 pain medicine providers in Wisconsin.
Other pain medicine in Menasha
- Alaa Abd-ElsayedMadison$1.3M
- Michael JungWest Bend$339K
- Frederick FreitagMadison$157K
- Atit ShahSheboygan$76K
- Thomas FaullMadison$66K
- Ammar MahmoudNeenah$57K
- Jeremy ScarlettSheboygan$40K
- Thomas StaussGreenfield$34K
- Matthew FischerAppleton$21K
- Jeffrey QuintanaMilwaukee$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.